Yazar "Kahraman, N." için listeleme
-
Novel inhibitors of eukaryotic elongation factor 2 kinase: in silico, synthesis and in vitro studies
Önder, F.C.; Durdağı, S.; Kahraman, N.; Uslu, T.N.; Kandemir, Hakan; Atıcı, E.B.; Ay, M. (Academic Press Inc., 2021)Eukaryotic elongation factor 2 kinase (eEF2K) is an unusual alpha kinase whose expression is highly upregulated in various cancers and contributes to tumor growth, metastasis, and progression. More importantly, eEF2K ... -
Target-Driven Design of a Coumarinyl Chalcone Scaffold Based Novel EF2 Kinase Inhibitor Suppresses Breast Cancer Growth in Vivo
Cömert Önder, F.; Kahraman, N.; Bellur Atıcı, E.; Cagır, A.; Kandemir, Hakan; Tatar, G.; Özpolat, Bülent (American Chemical Society, 2021)Eukaryotic elongation factor 2 kinase (eEF-2K) is an unusual alpha kinase involved in protein synthesis through phosphorylation of elongation factor 2 (EF2). eEF-2K is highly overexpressed in breast cancer, and its activity ...